Professional Documents
Culture Documents
Genomes:
Pek çok insan, genomlarımızın birbirinden çok farklı olduğuna inanıyor.
Ancak, türümüzün genom varyasyonlarının yüzdesi göz önüne alındığında,
iki insanın genom dizilimleri aslında yüzde 99,9 oranında aynıdır.
Kalan yüzde 0,1 bizi benzersiz kılan şeydir. [1]Fakat sistem gerçekte nasıl
çalışıyor?
1. Collins F.S ,Mansourahttps M.K(2001,Jan).The Human Genome Project. Revealing the shared inheritance of all
humankind. Cancer.1;91(1 Suppl):221-5. NCBI.
https://pubmed.ncbi.nlm.nih.gov/11148583/#:~:text=The%20Human%20Genome%20Project%20has,99.9%2
5%20at%20the%20DNA%20level.
2. Biological Sciences Curriculum Study(2007). NIH Curriculum Supplement Series[Internet].
NCBI.from,https://www.ncbi.nlm.nih.gov/books/NBK20363/
3. Shastry B.S(2009).SNPs: Impact on Gene Function and Phenotype.578:3-22. NCBI.
https://pubmed.ncbi.nlm.nih.gov/19768584/
4. Karki R., Pandya D., Elston R.S., Ferlini C.(2015). Defining “mutation” and “polymorphism” in the era of
personal genomics. BMC Medical Genomics volume 8,Article number: 37. Springer Link.
https://link.springer.com/article/10.1186/s12920-015-0115-z
5. Mattick J.S, Dziadek M.A,Terrill B.T, Kaplan
W., Spigelman A.D, Bowling F.G., Dinger M.E(2014).The impact of
genomics on the future of medicine and health. Med J Aust.201 (1): 17-20. from,
https://www.mja.com.au/journal/2014/201/1/impact-genomics-future-medicine-and-health
6. West M.,Ginsburg G.S.,Huang A.T.,Nevins J.R(2006).Embracing the complexity of genomic data for
personalized medicine.Genome Res. 2006. 16: 559-566.from,
https://genome.cshlp.org/content/16/5/559.short
7. Saravanan K.A.,Panigrahi M.,Kumar H.,Rajawat D.,Nayak S.S.,Bhushan B.,Duttb T.(2022).Role of genomics in
combating COVID-19 pandemic. NCBI. from,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894692/
8. Pang T.(2002). The Impact of Genomics on Global Health. American Journal of Public Health. NCBI.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1447192/
9. Bielinski S.J., Olson J.E.,Pathak J.,Weinshilboum R.M.,Wang L.,Lyke K.J.,Ryu E.,Targonski P.V.,Van Norstrand
M.D., Hathcock M.A.,Takahashi P.Y., McCormick J.B.,Johnson K.J.,Maschke K.J.,Rohrer Vitek C.R.,Ellingson M.S.,
Wieben E.D.,Farrugia G.,Morrisette J.A., Kruckeberg K.J.,Bruflat K.J., Peterson L.M., Blommer J.H., Skierka J.M,
Ferber M.J,Black J.L , Baudhuin L.M.,Klee E.W.,Ross J.L , Veldhuizen T.L.,Schultz C.G,Caraballo P.J., Freimuth R.R,
Chute C.G., Kullo I.J.(2014). Preemptive Genotyping for Personalized Medicine: Design of the Right Drug, Right
Dose, Right Time—Using Genomic Data to Individualize Treatment Protocol.Mayo Clinic Proceedings.Volume
89, 25-33. from, https://www.sciencedirect.com/science/article/abs/pii/S0025619613009294